Page last updated: 2024-11-08
dansylhydrazide trivaline
Description
dansylhydrazide trivaline: do not confuse trivaline (the tripeptide) with trivaline, synonym to amantidine sulfate (Merck, 9th ed, in #377); structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 195894 |
| MeSH ID | M0085568 |
Synonyms (12)
| Synonym |
|---|
| dansylhydrazide trivaline |
| 76080-91-6 |
| (2s)-2-amino-n-[(2s)-1-[[(2s)-1-[2-[5-(dimethylamino)naphthalen-1-yl]sulfonylhydrazinyl]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-3-methylbutanamide |
| trivaline dansyl hydrazide |
| val-val-val-dansyl hydrazide |
| l-valine, n-(n-l-valyl-l-valyl)-, 2-((5-(dimethylamino)-1-naphthalenyl)sulfonyl)hydrazide |
| dgtv |
| h-val-val-val-n2h2-dns |
| 2-amino-n-{1-[(1-{2-[5-(dimethylamino)naphthalene-1-sulfonyl]hydrazinylidene}-1-hydroxy-3-methylbutan-2-yl)imino]-1-hydroxy-3-methylbutan-2-yl}-3-methylbutanimidic acid |
| DTXSID70997413 |
| (s)-2-amino-n-((s)-1-(((s)-1-(2-((5-(dimethylamino)naphthalen-1-yl)sulfonyl)hydrazinyl)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)-3-methylbutanamide |
| AKOS040751398 |
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.98
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 11.98 (24.57) | | Research Supply Index | 2.64 (2.92) | | Research Growth Index | 4.62 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 13 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |